Katherine Goodrich serves as Executive at Tarsus Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Katherine Goodrich has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 15, 2025 involved exercising options for 2,233 shares valued at $0.
Katherine Goodrich currently holds 4,467 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Katherine Goodrich has been a net neutral trader of TARS stock. They have purchased $0 and sold $0 worth of shares.
Katherine Goodrich's most recent insider trade was on Dec 15, 2025, when they sold 2,233 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |